BAD and type 1 diabetes mellitus: In agreement with our results, previous work has reported that the upregulation of Bad and fasL along with downregulation of BCL-XL has been detected in PBMCs of patients with T1DM, serving as potential biomarkers of clinical remission (de Oliveira et al., 2012).